Duloxetine for the Treatment of Generalized Anxiety Disorder

NCT00803361 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

210

Enrollment

INDUSTRY

Sponsor class

Conditions

Generalized Anxiety Disorder

Interventions

DRUG: Duloxetine
DRUG: Placebo

Sponsor

Eli Lilly and Company

Collaborators

[object Object]